Overview

Using Gum Arabic for Cancer Patients to Protect From Oral Mucositis Caused by Chemotherapy: ِِِAn Experimental Study

Status:
Completed

Trial end date:
2016-08-01

Target enrollment:
0

Participant gender:
All

Summary

This study was designed to investigate the effect of Gum Arabic (GA) on cancer patients to prevent chemotherapy-induced oral mucositis. Cancer patients who will receive chemotherapy were divided into two groups; study "Gum Arabic" group (which received GA with chemotherapy) and control group (chemotherapy alone); and the participants were recruited to reach 190 patients in the study group and 184 patients in control group. This clinical trial was conducted in outpatient chemotherapy sections at Radiation and Isotopes Center of Khartoum. This study was designed to test the theory that say the chemotherapy-induced oral mucositis will significantly decrease after ingestion 30 grams as daily dose of Gum Arabic in a form of solution for six weeks during therapy.

Phase:

Phase 2

Accepts Healthy Volunteers?

Details

Lead Sponsor:

University of Science and Technology, Yemen

Criteria

Inclusion Criteria:

- Patients whom well diagnosed with cancer in any stage were eligible for enrolment if
chemotherapy is part of their treatment plan.

Exclusion Criteria: Patients were excluded if

- they had received recent previous chemotherapy or radiotherapy,

- they had oral mucositis or periodontitis,

- there is evidence of any systemic diseases.